Featured News
More News
Breaking down diabetes: Insulin, unwelcome, but underutilized
During my medical training in the 1990s, I was taught that insulin was a last resort after patients with Type 2 diabetes had “failed” oral medications, meaning their blood sugar remained worryingly high.
Using antibody in treatment of ‘bubble boy disease’ shows early promise
In a clinical trial, participants were given an antibody to CD117, a cell surface marker, in an effort to wipe out their defective blood stem cells without high-risk chemotherapy or radiation.
Breaking down diabetes: Drugs for diabetes, starting with the best — metformin
A huge assortment of 100 medications are available to treat high blood sugar in Type 2 diabetes, including two historical breakthrough drugs, insulin and metformin.
Gerald Reaven, scientist who coined ‘Syndrome X,’ dies at 89
Gerald Reaven’s decades of research at Stanford helped show that insulin resistance could lead to Type 2 diabetes and multiple other diseases.
Low-fat or low-carb? It’s a draw, study finds
Stanford researchers have found that, contrary to previous studies, insulin levels and a specific genotype pattern don’t predict weight-loss success.
New AI-powered algorithm offers a more accurate, accessible method for diagnosing diabetes subtypes and tailoring treatments, with potential for widespread impact.